Next 10 |
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $300,000 In Decision Diagnostics Corp. To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - February 7, 2021) - Faruqi & Faruqi, LLP, a leading national s...
Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $300,000 In Decision Diagnostics Corp. To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - January 24, 2021) - If you suffered losses exceeding $300,000 investing ...
Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $300,000 In Decision Diagnostics Corp. To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - January 20, 2021) - If you suffered losses exceeding $300,000 investing ...
Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $300,000 In Decision Diagnostics Corp. To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - January 18, 2021) - If you suffered losses exceeding $300,000 inve...
The company and its CEO thank supporters and remain fully committed; company will also provide a series of GenViro! test results it has amassed demonstrating the technology's promise LOS ANGELES, CA / ACCESSWIRE / December 21, 2020 / Decision Diagnostics Corp. (OTC PINK:DECN) www.deci...
LOS ANGELES, CA / ACCESSWIRE / December 18, 2020 / Decision Diagnostics Corp. (OTC PINK:DECN) www.decisiondiagnostics.co , a leading manufacturer and worldwide distributor of diabetic test strips engineered to operate on legacy glucose meters through its subsidiary Pharma Tech Solutions, In...
As clinical testing in Pennsylvania nears completion for pro and point of care GenViro! kits, Korean partner initiates PCR validation testing to augment testing of their saliva donors and the XPRIZE samples DECN plans 150 patient donor study to complete its at-home testing kit EUA L...
Decision Diagnostics ([[DECN]] +3.0%) through its subsidiary Pharma Tech Solutions signed an exclusive distribution agreement for its Genviro! testing product with a Deusseldorf, Germany-based distribution company currently doing business in 20 European countries.New agreement covers sal...
WITH THIS DEAL THE TOTAL NUMBER OF COUNTRIES COVERED BY DECN INTERNATIONAL AGREEMENTS NOW APPROACHES 50 WITH MORE ANTICIPATED LOS ANGELES, CA / ACCESSWIRE / December 10, 2020 / Decision Diagnostics Corp. (OTC PINK:DECN) www.decisiondiagnostics.co , a leading manufacturer and worldwide ...
Company Continues to Pursue Global Distribution Agreements During the "Home Stretch" in U.S. Based FDA Level Testing LOS ANGELES, CA / ACCESSWIRE / December 1, 2020 / Decision Diagnostics Corp. (OTC PINK:DECN) www.decisiondiagnostics.co , a leading manufacturer and worldwide distributo...
News, Short Squeeze, Breakout and More Instantly...
Decision Diagnostics Corp Company Name:
DECN Stock Symbol:
OTCMKTS Market:
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $300,000 In Decision Diagnostics Corp. To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - February 7, 2021) - Faruqi & Faruqi, LLP, a leading national s...
Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $300,000 In Decision Diagnostics Corp. To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - January 24, 2021) - If you suffered losses exceeding $300,000 investing ...
Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $300,000 In Decision Diagnostics Corp. To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - January 20, 2021) - If you suffered losses exceeding $300,000 investing ...